NCT04234113 2026-03-27
Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Phase 1 Terminated
Clinical Trials
44 trialsNCT04483544 2025-04-29
Pembrolizumab and Olaparib in Cervical Cancer Patients
Baptist Health South Florida
Phase 2 Terminated
NCT04514692 2025-04-23
Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging
Stanford University
Phase 1/2 Terminated
NCT03527264 2025-04-04
BrUOG 355: Nivolumab to Tailored Radiation Therapy With Concomitant Cisplatin in the Treatment of Patients With Cervical Cancer
Brown University
Phase 2 Terminated
NCT03829501 2025-04-02
A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies
Kymab Limited
Phase 1/2 Terminated
NCT05012397 2024-10-17
Milademetan in Advanced/Metastatic Solid Tumors
Rain Oncology Inc
Phase 2 Terminated
NCT03644342 2024-09-03
NIVIX
Baylor College of Medicine
Phase 1/2 Terminated
NCT01284348 2024-08-29
To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC
Phase 2 Terminated
NCT03439085 2024-07-09
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT03367871 2024-06-18
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer
University of Miami
Phase 2 Terminated
NCT03345784 2024-02-20
Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers
National Cancer Institute (NCI)
Phase 1 Terminated
NCT04585243 2023-10-11
Self-sampling for Human Papillomavirus (HPV) Among Patients Receiving Colposcopy
Milton S. Hershey Medical Center
Phase NA Terminated
NCT04591977 2023-10-06
Self-Sampling for Human Papillomavirus (HPV) at Well Women Appointments
Milton S. Hershey Medical Center
Phase NA Terminated
NCT04171700 2023-10-02
LODESTAR
pharmaand GmbH
Phase 2 Terminated
NCT01076400 2023-09-18
MK-1775-008
Merck Sharp & Dohme LLC
Phase 1/2 Terminated
NCT00794339 2023-08-14
ACRIN6682
American College of Radiology
Phase 2 Terminated
NCT04066894 2023-08-14
Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01234480 2023-05-16
Intended Use Study of the BD SurePath Plus™ Pap
Becton, Dickinson and Company
Terminated
NCT02291055 2023-03-20
A Study of ADXS11-001 or MEDI4736 Alone or Combination In Cervical or Human Papillomavirus (HPV)+ Head & Neck Cancer
Advaxis, Inc.
Phase 1/2 Terminated
NCT03386721 2023-02-21
Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors
Hoffmann-La Roche
Phase 2 Terminated
NCT04476251 2021-12-15
E7 TCR T Cell Induction Immunotherapy for Stage IIB-IVA Cervical Cancer
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Terminated
NCT00900562 2021-10-28
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
PharmaMar
Phase 2 Terminated
NCT01902966 2021-10-12
Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX)
M.D. Anderson Cancer Center
Phase NA Terminated
NCT04099277 2021-08-31
A Study of LY3435151 in Participants With Solid Tumors
Eli Lilly and Company
Phase 1 Terminated
NCT03277352 2021-07-22
INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies
Incyte Corporation
Phase 1/2 Terminated
NCT00978874 2021-06-25
Fluorine F 18 EF5 PET/CT Imaging in Patients With Locally Advanced or Recurrent/Metastatic Cervical Cancer
Abramson Cancer Center at Penn Medicine
Phase NA Terminated
NCT00577317 2021-06-23
Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer
GOG Foundation
Phase 3 Terminated
NCT01016561 2021-05-05
Magnetic Resonance Imaging-Based Radiation Therapy and Cisplatin in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer
Abramson Cancer Center at Penn Medicine
Phase NA Terminated
NCT03423082 2020-10-28
Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Cancer.
University of Pittsburgh
Phase 4 Terminated
NCT00924066 2019-11-21
Ixabepilone to Treat Cervical Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT01583686 2019-10-14
CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
Phase 1/2 Terminated
NCT03613493 2019-08-02
Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention
University of Miami
Phase NA Terminated
NCT00262821 2019-07-23
Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
National Cancer Institute (NCI)
Phase 3 Terminated
NCT02153905 2019-06-17
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive
National Institutes of Health Clinical Center (CC)
Phase 1/2 Terminated
NCT01958112 2019-05-31
GSK1120212+GSK2141795 for Cervical Cancer
Dana-Farber Cancer Institute
Phase 2 Terminated
NCT02509585 2019-02-11
A Trial of Comparing the Pathology Status of Lymphoseek®-Identified Sentinel Lymph Nodes Relative to the Pathological Pathology Status of Nonsentinel Lymph Nodes in Nodal Staging of Subjects With Known Cancer of the Cervix Who Are Undergoing Lymph Node Dissection
Cardinal Health 414, LLC
Phase 2 Terminated
NCT01075412 2017-12-02
FLT PET Imaging for Cervical Cancer
University of Iowa
Phase 2 Terminated
NCT00070317 2017-11-06
Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer
GOG Foundation
Phase NA Terminated
NCT00590967 2016-08-29
A Phase II Study of Extended Field IMRT External Beam Irradiation and Intracavitary Brachytherapy
Washington University School of Medicine
Phase 2 Terminated
NCT00529464 2016-05-09
Spectroscopy Versus Standard Care in Cervical Cancer Patients
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00966992 2015-09-09
Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer
Washington University School of Medicine
Phase 2 Terminated
NCT00626561 2014-07-07
Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00138151 2013-11-20
Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer
Rutgers, The State University of New Jersey
Phase 2 Terminated
NCT00085631 2013-09-17
Cisplatin and Radiation Therapy With or Without Hyperthermia Therapy in Treating Patients With Cervical Cancer
Duke University
Phase 3 Terminated